Global Collaborations and Impacts
Concord Medical has extensive experience in proton therapy operations. As the former majority shareholder of the MD Anderson Proton Therapy Center’s management company, it gained significant expertise in both clinical treatment and operational management.
Forging Strong Collaborations to Develop New Frontiers in China’s Cancer Care
With the rapid economic development in China and continuous opening up to the world, population health is of prime importance to China. Hence healthcare reform is among top priorities with the aim of broadening access and enhancing care quality through promotion of different forms of local-foreign partnerships. With this supportive environment, GCCC has carried out in-depth cooperation with top-level medical institutions domestic and abroad, aiming to create new frontiers in China’s cancer care.
Concord Medical has extensive experience in proton therapy operations. As the former majority shareholder of the MD Anderson Proton Therapy Center’s management company, it gained significant expertise in both clinical treatment and operational management.
MD Anderson Cancer Center
Internationally renowned cancer prevention, research, education and prevention institution.
The mission is to eradicate cancer through clinical prevention, research,prevention and education in Texas, the United States and around the world.
For successive years, ranked NO.1 in the "best cancer hospitals in the United States" published by US News and World Report.
GCCC has collaborated with MD Anderson Cancer Center in phase । construction, staff training and hospital operation and management.
Mayo Clinic
One of the highest level medical institutions in the world.
Ranked NO.1 in the "best hospitals in the United States" published by the "US News and World Report" for many times.
Based on the continuous innovation of medical education and the world's leading medical research, have established a comprehensive medical system with the largest scale and the most advanced equipment in the United States.
As a strategic partner, Mayo Clinic will carry out in-depth cooperation with GCCC in terms of quality, diagnosis and treatment mode, medical education, innovation and patient experience to build an international cancer hospital with Chinese characteristics.
Global Impacts: Indonesian Consul General Visits GCCC
On the afternoon of October 13, 2022, Mr. Ben Perkasa Drajat, Consul General of Indonesia in Guangzhou, and Mr. Kurniawan Wibowo, Head of Social and Cultural Affairs, along with their delegation, visited Guangzhou Concord Cancer Center for an inspection and exchange. President Qian Chaonan, along with Assistant Presidents, warmly received the delegation and accompanied them on the tour and discussion.
After gaining a comprehensive understanding of the hospital, the Consul General praised the hospital's advanced medical equipment, strict medical standards, patient-centered service philosophy, and comfortable treatment environment. He expressed his hope that Indonesian specialty hospitals could collaborate with GCCC to serve the broader cancer patient population in Indonesia and surrounding regions.
Through this exchange visit, both sides deepened mutual understanding and strengthened their friendship. President Qian Chaonan expressed his gratitude to the Consul General and his delegation for their care, attention, and support for the hospital’s development, and conveyed his hope for closer cooperation with Indonesia to bring greater benefits to more patients.